Lankin Vadim Z, Tikhaze Alla K, Sharapov Mars G, Konovalova Galina G
Department for Free Radical Biochemistry, E.I. Chazov' National Medical Research Center of Cardiology, Russian Ministry of Health, 121552 Moscow, Russia.
Institute of Cell Biophysics, Russian Academy of Sciences, 142290 Pushchino, Moscow, Russia.
Rev Cardiovasc Med. 2024 Aug 20;25(8):295. doi: 10.31083/j.rcm2508295. eCollection 2024 Aug.
This review summarises the data from long-term experimental studies and literature data on the role of oxidatively modified low-density lipoproteins (LDL) in atherogenesis and diabetogenesis. It was shown that not "oxidized" (lipoperoxide-containing) LDL, but dicarbonyl-modified LDL are atherogenic (actively captured by cultured macrophages with the help of scavenger receptors), and also cause expression of lectin like oxidized low density lipoprotein receptor 1 () and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 1 () genes in endotheliocytes, which stimulate apoptosis and endothelial dysfunction. The obtained data allowed us to justify new approaches to pharmacotherapy of atherosclerosis and diabetes mellitus.
本综述总结了长期实验研究数据以及文献数据,这些数据涉及氧化修饰的低密度脂蛋白(LDL)在动脉粥样硬化形成和糖尿病发生中的作用。结果表明,具有致动脉粥样硬化作用(在清道夫受体的帮助下被培养的巨噬细胞主动摄取)的并非“氧化的”(含脂过氧化物的)LDL,而是二羰基修饰的LDL,并且它还会导致内皮细胞中凝集素样氧化低密度脂蛋白受体1( )和烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶1( )基因的表达,从而刺激细胞凋亡和内皮功能障碍。所获得的数据使我们能够论证动脉粥样硬化和糖尿病药物治疗的新方法。